<p>Seven days after the last immunization with pVAX1-Sj26GST, alone or with CpG, R848, or both (CpG+R848), splenocytes from each mouse were analyzed by flow cytometry analysis for CD3, CD4, CD25, and Foxp3 expression. The mean fold change of the percentage of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Tregs in mice at week 0 compared with 5 weeks after immunization with the indicated formulations is shown. Groups consisted of 6 mice at each time point. The results are expressed as the mean ± SEM of 12 mice from 2 independent experiments. ** <i>P</i><0.01.</p
<p>(A) Splenocytes from CD150 or nontransgenic mice (control), inoculated i.n. with either MV or med...
<p>Mice were injected with anti-CD25 antibody or with PBS only. 7 days later, mice depleted from CD2...
<p>(<b>A</b>) Spenocytes (1×10<sup>6</sup>) were isolated from spleen of infected, differently vacci...
<p>Splenocytes from naïve mice were stimulated <i>in vitro</i> with 3 µg/mL CpG, R848, or both for 4...
<p>Seven days after the last immunization with pVAX1-Sj26GST, alone or with CpG, R848, or both (CpG+...
<p>(A) Seven days after the last immunization with pVAX1-Sj26GST alone or with CpG, R848, or both (C...
<p>Isolated CD4<sup>+</sup>CD25<sup>−</sup> T cells (1×10<sup>5</sup>/well) from naïve mice were cul...
<p>C57BL/6 mice (6 mice per group) were injected with pVAX1-Sj26GST (50 µg), with or without 25 µg C...
<p>A). At 12<sup>th</sup> day after tumor implantation and after one time VLP vaccination at day 3, ...
<p>At day 5 post-infection, spleen cells from individual mice (4 mice per group) were stained with t...
<p>A) C57Bl/6 mice were administered 10 nmol CpG i.v. or left untreated. Eighteen hours later spleen...
<p>A–D) Non-transgenic (non-Tg) and 11c.OVA mice were administered CpG or not and CD45.1+ OT-I T cel...
<p>Percentages of Foxp3<sup>+</sup> cells were assessed in spleen, inguinal lymph nodes and pancreat...
<p>BALB/c mice immunized with gp96 three times were challenged with Con A. At 12 h after the Con A c...
<p>B6 mice were treated with recombinant IL-2 alone, anti-IL-2 alone, immunization with vector, MHC ...
<p>(A) Splenocytes from CD150 or nontransgenic mice (control), inoculated i.n. with either MV or med...
<p>Mice were injected with anti-CD25 antibody or with PBS only. 7 days later, mice depleted from CD2...
<p>(<b>A</b>) Spenocytes (1×10<sup>6</sup>) were isolated from spleen of infected, differently vacci...
<p>Splenocytes from naïve mice were stimulated <i>in vitro</i> with 3 µg/mL CpG, R848, or both for 4...
<p>Seven days after the last immunization with pVAX1-Sj26GST, alone or with CpG, R848, or both (CpG+...
<p>(A) Seven days after the last immunization with pVAX1-Sj26GST alone or with CpG, R848, or both (C...
<p>Isolated CD4<sup>+</sup>CD25<sup>−</sup> T cells (1×10<sup>5</sup>/well) from naïve mice were cul...
<p>C57BL/6 mice (6 mice per group) were injected with pVAX1-Sj26GST (50 µg), with or without 25 µg C...
<p>A). At 12<sup>th</sup> day after tumor implantation and after one time VLP vaccination at day 3, ...
<p>At day 5 post-infection, spleen cells from individual mice (4 mice per group) were stained with t...
<p>A) C57Bl/6 mice were administered 10 nmol CpG i.v. or left untreated. Eighteen hours later spleen...
<p>A–D) Non-transgenic (non-Tg) and 11c.OVA mice were administered CpG or not and CD45.1+ OT-I T cel...
<p>Percentages of Foxp3<sup>+</sup> cells were assessed in spleen, inguinal lymph nodes and pancreat...
<p>BALB/c mice immunized with gp96 three times were challenged with Con A. At 12 h after the Con A c...
<p>B6 mice were treated with recombinant IL-2 alone, anti-IL-2 alone, immunization with vector, MHC ...
<p>(A) Splenocytes from CD150 or nontransgenic mice (control), inoculated i.n. with either MV or med...
<p>Mice were injected with anti-CD25 antibody or with PBS only. 7 days later, mice depleted from CD2...
<p>(<b>A</b>) Spenocytes (1×10<sup>6</sup>) were isolated from spleen of infected, differently vacci...